The company plans to unveil a clinically studied ingredient on opening day and host a longevity session alongside its cognitive, mobility, and metabolic health portfolio.
|Articles|January 6, 2012
Enzymotec Gains New Patent for Omega-Sterols
Manufactured by Enzymotec (Migdal HaEmek, Israel), the ingredient is clinically proven to provide cardiovascular benefits.
Advertisement
Omega-Sterols, a patented ingredient comprising “naturally occurring hybrids of phytosterols and omega-3,” has garnered an Australian patent (No. AU-0552025002). Manufactured by Enzymotec (Migdal HaEmek, Israel), the ingredient is clinically proven to provide cardiovascular benefits, including for blood lipid control and support of health levels of blood triglycerides and LDL cholesterol.
The Australian patent addresses Omega-Sterols’ benefits as a functional food for diabetics. Enzymotec says the patent is part of five different patents that cover the ingredient’s properties, composition, and methods of use.
Advertisement
Related to this article
With Peru's anchovy fishery opening its 2026 season with its lowest quota in a decade, Matts Johansen argues that aquaculture's growing appetite for omega-3s, not just El Niño, is what should actually be keeping supplement brands up at night.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Research on Herbs, Spices, and Metabolic Health
2
SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition
3
Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods
4
The Reason Behind Pairing Sea Buckthorn Oil and Thymoquinone
5